The 2003 Canadian recommendations for dyslipidemia management: revisions are needed
Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. CMAJ. 2005; 172(8):1027-31.
Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. CMAJ. 2005; 172(8):1027-31.
Tu JV, Pinfold SP, McColgan P, Laupacis A, editors. April 2005
Needham DM, Bronskill SE, Calinawan JR, Sibbald WJ, Pronovost PJ, Laupacis A. Crit Care Med. 2005; 33(3):574-9.
Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Diabetes Care. 2005; 28(3):600-6.
Battistella M, Mamdani MM, Juurlink DN, Rabeneck L, Laupacis A. Arch Intern Med. 2005; 165(2):189-92.
Juurlink DN, Mamdani MM, Kopp A, Herrmann N, Laupacis A. Br J Clin Pharmacol. 2005; 59(1):102-7. Epub 2004 Dec 16.
Tran CT, Laupacis A, Mamdani MM, Tu JV. Am Heart J. 2004; 148(5):834-41.
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. N Engl J Med. 2004; 351(6):543-51.
Humphries KH, Jackevicius C, Gong Y, Svensen L, Cox J, Tu JV, Laupacis A; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2004; 20(9):869-76.
Needham DM, Bronskill SE, Sibbald WJ, Pronovost PJ, Laupacis A. Crit Care Med. 2004; 32(7):1504-9.